Navigation Links
Ohio Becoming Global Hub for Biomedical Research and Commercialization
Date:11/12/2008

BioInnovation Institute combines Ohio's strengths in the polymer industry

and medical fields to spark biomedical innovation

COLUMBUS, Ohio, Nov. 12 /PRNewswire/ -- Ohio aims to become a global hub for biomedical research, commercialization and innovation after the recent launch of the BioInnovation Institute located in Akron, Ohio. According to the Ohio Business Development Coalition, the nonprofit organization that markets the state for capital investment, the BioInnovation Institute will bring together Ohio's world-class organizations, researchers and educators in the polymer industry and biomaterials and biomedical fields to generate the next generation of life-enhancing innovation for the 21st century.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071107/CLW113LOGO )

The result of public-private partnerships from organizations throughout the state, the BioInnovation Institute will create a nationally distinctive center of excellence by drawing talent from across the globe, increase annual funding for Ohio's polymer industry and biomedical research, increase investment by national firms into the state and bring thousands of new jobs to Ohio by 2018.

"The BioInnovation Institute in Akron is uniquely positioned to meld the state's traditional strengths in research and education in both the polymer industry and biomedical excellence to create transformational new technologies with a direct impact on the people we collectively serve," said William H. Considine, chairman of the BioInnovation Institute and president and chief executive officer of Akron Children's Hospital. "Our vision of making Akron, and the state of Ohio, a national leader in the biomedical field is absolutely attainable given our intellectual, educational, research and commercial strengths."

Founders of the BioInnovation Institute include Akron Children's Hospital, Akron General Health System, Northeastern Ohio Universities Colleges of Medicine and Pharmacy (NEOUCOM), Summa Health System and The University of Akron. Faculty members will include researchers, physicians and educators from the partner organizations.

The John S. and James L. Knight Foundation led the funding effort to create the BioInnovation Institute with a $20 million grant. Supporting partners have secured $80 million overall for the project. The state of Ohio also has contributed more than $8 million through the Ohio Third Frontier Project, a 10-year, $1.6 billion initiative to help catalyze connections between companies and academia. The project is the state's largest-ever commitment to expanding high-tech research capabilities and promoting innovation and company formation that will create high-paying jobs for generations to come.

"Ohio leads the world in advanced materials capability and is rapidly becoming a global leader in the bioscience industry. The cross fertilization of knowledge between these two industries has the potential to lead to commercial innovations that will dramatically improve lives. It will also stimulate new capital investment in our economy," said Ed Burghard, executive director of the Ohio Business Development Coalition. "Companies are attracted to the bottom-line benefits generated from the superior work-life balance found in Ohio. Ohio's low-cost, low stress communities and combination of micropolitan and metropolitan cities provides executives and employees the resources and time to make any ambition achievable. Ohio truly is the state of perfect balance."

About the Ohio Business Development Coalition

The Ohio Business Development Coalition is a nonprofit organization that markets the state for capital investment. The OBDC provides marketing strategy and implementation to support Ohio's economic development efforts. For more information on business development or business relocation, visit http://www.ohiomeansbusiness.com.


'/>"/>
SOURCE Ohio Business Development Coalition
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Alkemists Sets The Bar, Becoming a 'Green' Analytical Laboratory
2. Calorimeters and Thermal Analysis Equipment Market to Exceed $539 Million by 2012, According to New Report by Global Industry Analysts
3. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
4. New Generation Biofuels CEO to Present at the Rodman & Renshaw Annual Global Investment Conference
5. Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
6. AMDL, Inc. New President & CEO Douglas MacLellan to Present at Rodman & Renshaw Annual Global Investment Conference November 12, 2008
7. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
8. Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts
9. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
10. The Female Health Company to Present at Rodman & Renshaw 10th Annual Global Investment Conference
11. Transdel Pharmaceuticals to Present at Rodman & Renshaw 10th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... (PRWEB) , ... February 04, 2016 , ... ... latest GC-MS and triple quad LC-MS, host live demos and poster sessions, and ... conference and exhibition. The conference takes place March 6 to 10 at the ...
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 /PRNewswire/ ... "Company"), a biopharmaceutical company focused on the development and commercialization ... at the 18 th Annual BIO CEO & ... a.m. EST in New York, NY . ... will provide an update on the ongoing clinical trial of ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, ... with the first pluripotent stem cell-derived islet replacement ... in clinical-stage development, today announced that ViaCyte and ... Companies of Johnson & Johnson, have agreed to ... into ViaCyte.  The agreement provides ViaCyte with an ...
Breaking Biology Technology:
(Date:2/1/2016)... ( www.wocketwallet.com ) announces the launch of a new video featuring singer, ... Las Vegas , where Joey appeared at the Wocket booth to ... , where Joey appeared at the Wocket booth to meet and greet ... the Consumer Electronics Show (CES2016) in Las Vegas , ... --> --> The video is ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
(Date:1/20/2016)... Jan. 20, 2016  Synaptics Incorporated (NASDAQ: ... solutions, today announced sampling of S1423, its newest ... and small screen applications including smartwatches, fitness trackers, ... round and rectangular shapes, as well as thick ... with moisture on screen, while wearing gloves, and ...
Breaking Biology News(10 mins):